www.fdanews.com/articles/131778-j-38-j-in-talks-to-resolve-probe-of-risperdal-marketing

J&J in Talks to Resolve Probe of Risperdal Marketing

November 11, 2010

Johnson & Johnson [J&J] said it’s in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal.
Fox Business